Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Traceable Thermometer

By Drug Discovery Trends Editor | November 9, 2012

Control Company’s traceable memory-card humidity/temperature/dew point is a stand-alone unit with data logging capabilities. Stores readings from once a minute to once every 720 minutes on a removable standard SD memory card—identical to cards in digital cameras. Memory reader (supplied) plugs into any USB computer port—no software to install. Text report includes date, time of day, sensor readings and may be sent to any spreadsheet or database. Unit monitors incubators, clean rooms, store rooms, labs, hoods, and any critical areas. Records 5.9 million readings (over 10 years of minute-by-minute readings) and has 256 mb memory card (up to 4 gig card may be used).

Temperature range is 0 to 50.0°C with 0.1° resolution and ±1°C accuracy. Humidity range is 0.0 to 90.0 RH with 0.1 resolution; accuracy is  ±5%RH at 25°C in range of 20 to 85%RH and  ±7%RH elsewhere. Dew point range is -20.0 to 50.0°C with 0.1° resolution.

Minimum/maximum feature displays highest/lowest readings for any time period. Alarm beeps and bright red LED flashes when temperature, humidity, and dew point rise above or fall below user-set trip points. Alarm can be set in 0.1 increments.  Unique 4-line display simultaneously shows ambient temperature, humidity, dew point, and time of day. Operates using supplied batteries and/or supplied adaptor. Case is high-impact, chemical-resistant ABS plastic.

Control Company


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE